Respiratory Failure
Conditions
Keywords
Ecmo, Neonates
Brief summary
Investigation of the association between PaCO2 change after extra corporeal membrane oxygenation (ECMO) initiation and neurological outcome and mortality in neonates treated by ECMO for respiratory failure.
Detailed description
Retrospective analysis of the ELSO database investigating the association between the change of PCO2 value after ECMO start and the risk of acute neurological event under ECMO defined by the onset of cerebral bleeding and/or ischemic stroke and/or clinical or electrical seizure and/or brain death.
Interventions
Neonates (\<28 j) supported by ECMO for severe respiratory failure
Sponsors
Study design
Eligibility
Inclusion criteria
: * Support by ECMO for respiratory indication
Exclusion criteria
: * None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Acute Neurological Event | Up to 90 days after ECMO initiation | Onset of cerebral bleeding and/or ischemic stroke and/or clinical or electrical seizure and/or brain death. The outcome (ANE) was defined by the occurrence of almost one of the following item: * Ischemic or hemmorrhagic stroke diagnosed by ultrasounds, CT or MRI * Clinical or electrical seizures : diagnosed by ElectroEncepahloGraphy (EEG) * Brain death clinically diagnosed |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| 28-day mortality | 28 days after ECMO start | Newborns died after 28 days despite ECMO assistance |
Countries
France